Janus Henderson Group Portfolio holdings
Janus Henderson Group, formed in 2017 through the merger of Janus Capital Group (founded 1969) and Henderson Group (founded 1934), is a global asset management firm headquartered in London, managing over $350 billion in assets as of late 2024 for institutional, retail, and high-net-worth clients. With a strong presence in the U.S., Europe, and Asia-Pacific, the firm offers a wide range of investment products, including equities, fixed income, multi-asset, and alternative strategies, often blending active management with research-driven insights. Known for its equity expertise from Janus’s growth-focused heritage and Henderson’s European fixed-income strengths, Janus Henderson serves clients through mutual funds, ETFs, and bespoke portfolios, emphasizing risk-adjusted returns and ESG integration. Led by CEO Ali Dibadj since 2022, the publicly traded firm (NYSE: JHG) continues to refine its strategy amid competitive pressures, maintaining a foothold in key markets worldwide.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$868M |
| 2 |
Amazon
AMZN
|
+$726M |
| 3 |
UnitedHealth
UNH
|
+$571M |
| 4 |
Rivian
RIVN
|
+$559M |
| 5 |
TJX Companies
TJX
|
+$441M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Meta Platforms (Facebook)
META
|
+$1.09B |
| 2 |
NVIDIA
NVDA
|
+$762M |
| 3 |
L3Harris
LHX
|
+$742M |
| 4 |
Zurn Elkay Water Solutions
ZWS
|
+$497M |
| 5 |
Texas Instruments
TXN
|
+$477M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 32.51% |
| 2 | Healthcare | 18.41% |
| 3 | Consumer Discretionary | 11.39% |
| 4 | Financials | 9.7% |
| 5 | Industrials | 8.61% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
251
MSCI
MSCI
$42.1B
| $180M | 0.08% |
293,759
-30,030
| -9% | -$18.8M |
|
252
Brady Corp
BRC
$4.6B
| $179M | 0.07% |
3,329,778
+4,712
| +0.1% | +$247K |
|
253
Bio-Techne
TECH
$11.2B
| $179M | 0.07% |
1,384,932
+20,476
| +2% | +$2.51M |
|
254
CDW
CDW
$18.4B
| $179M | 0.07% |
871,833
-123,058
| -12% | -$23.4M |
|
255
Constellium
CSTM
$3.96B
| $178M | 0.07% |
9,943,448
-153,524
| -2% | -$2.82M |
|
256
Envista
NVST
$4.39B
| $177M | 0.07% |
3,934,723
+510,272
| +15% | +$21M |
|
257
Teradyne
TER
$50.2B
| $177M | 0.07% |
1,081,670
+289,567
| +37% | +$40.7M |
|
258
Willis Towers Watson
WTW
$29.9B
| $175M | 0.07% |
736,075
+505,603
| +219% | +$120M |
|
259
Insulet
PODD
$11.6B
| $175M | 0.07% |
656,523
-197,230
| -23% | -$57.2M |
|
260
Automatic Data Processing
ADP
$106B
| $173M | 0.07% |
702,635
+30,916
| +5% | +$7M |
|
|
OCDX
261
DELISTED
Ortho Clinical Diagnostics Holdings plc Ordinary Shares
OCDX
| $173M | 0.07% |
8,068,533
-169,553
| -2% | -$3.34M |
|
262
Hartford Financial Services
HIG
$39.3B
| $172M | 0.07% |
2,484,314
+554,465
| +29% | +$39.1M |
|
263
Goldman Sachs
GS
$305B
| $171M | 0.07% |
445,918
+80,431
| +22% | +$31.8M |
|
264
OSI Systems
OSIS
$3.64B
| $170M | 0.07% |
1,823,798
+15,143
| +0.8% | +$1.42M |
|
265
Capital One
COF
$130B
| $168M | 0.07% |
1,155,974
+147,108
| +15% | +$22.7M |
|
|
ENV
266
DELISTED
ENVESTNET, INC.
ENV
| $168M | 0.07% |
2,113,868
-81,822
| -4% | -$6.66M |
|
|
ARNA
267
DELISTED
Arena Pharmaceuticals Inc
ARNA
| $167M | 0.07% |
1,798,634
+561,482
| +45% | +$37M |
|
268
Core & Main
CNM
$8.23B
| $161M | 0.07% |
5,319,367
-53,944
| -1% | -$1.48M |
|
|
GBT
269
DELISTED
Global Blood Therapeutics, Inc.
GBT
| $160M | 0.07% |
5,483,164
-789,518
| -13% | -$24.5M |
|
270
Sempra
SRE
$59.2B
| $156M | 0.07% |
2,357,802
-18,710
| -0.8% | -$1.19M |
|
271
PTC Therapeutics
PTCT
$6.25B
| $155M | 0.06% |
3,901,397
+326,210
| +9% | +$12.5M |
|
272
Sun Communities
SUI
$15.3B
| $154M | 0.06% |
735,412
+27,225
| +4% | +$5.36M |
|
273
ITT
ITT
$17.8B
| $154M | 0.06% |
1,504,535
-143,897
| -9% | -$14.1M |
|
274
Clarivate
CLVT
$1.53B
| $154M | 0.06% |
6,537,173
+1,154,169
| +21% | +$26.7M |
|
|
IPG
275
DELISTED
Interpublic Group of Companies
IPG
| $153M | 0.06% |
4,080,473
+693,496
| +20% | +$25.2M |
|
Similar funds
Janus Henderson Group's Q4 2021 Portfolio in Review
As of Q4 2021, Janus Henderson Group held 2,654 positions worth $240B, up 4.9% from $229B the previous quarter. Its ten largest holdings account for 25% of the portfolio.
Janus Henderson Group's Q4 2021 filing shows 464 new, 1,324 increased, 690 reduced and 110 closed positions. Its largest new stake was Rivian: 4,856,003 shares worth $504M. The largest sale was Meta Platforms (Facebook), an estimated $1.09B.
By sector, the portfolio is most concentrated in Technology at 33% of assets, up from 31% a quarter earlier, followed by Healthcare and Consumer Discretionary.
- Janus Henderson Group's largest Q4 2021 buy was Rivian: 4,856,003 shares worth $504M.
- Janus Henderson Group added most to Apple in Q4 2021, an estimated $868M increase.
- Janus Henderson Group's biggest Q4 2021 reduction was Meta Platforms (Facebook), cutting an estimated $1.09B.
- Janus Henderson Group fully exited Acceleron Pharma in Q4 2021, selling an estimated $274M.
- Janus Henderson Group's ten largest holdings make up 25% of its $240B portfolio in Q4 2021.
- Janus Henderson Group opened 464 new positions and closed 110 in Q4 2021.
- Janus Henderson Group's portfolio value rose 4.9% quarter-over-quarter to $240B.
Based on Janus Henderson Group's 13F filing for Q4 2021, filed 14 Feb 2022.